Autosomal dominant nocturnal frontal lobe epilepsy: genes and variants
Explore variant evidence for Autosomal dominant nocturnal frontal lobe epilepsy across 4 analyzed proteins (CHRNA4, KCNT1, DEPDC5, GABRG2). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 306 variants of uncertain significance and 106 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal dominant nocturnal frontal lobe epilepsy
CHRNA4: Neuronal acetylcholine receptor subunit alpha-4
It contributes to neuronal nicotinic acetylcholine responses that regulate excitability and neurotransmitter release. Dominant gain-of-function variants classically cause sleep-related hypermotor epilepsy, formerly termed autosomal dominant nocturnal frontal-lobe epilepsy.
3 ClinVar pathogenic / likely pathogenic and 398 uncertain variants in CHRNA4 have source records linked to Autosomal dominant nocturnal frontal lobe epilepsy. Association strength is not clinical gene validity.
KCNT1: Potassium channel subfamily T member 1
Its sodium-activated potassium current helps shape repetitive neuronal firing and adaptation. Gain-of-function variants are a well-established cause of severe early-onset epilepsies, including epilepsy of infancy with migrating focal seizures and autosomal dominant sleep-related hypermotor epilepsy.
0 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in KCNT1 have source records linked to Autosomal dominant nocturnal frontal lobe epilepsy. Association strength is not clinical gene validity.
DEPDC5: GATOR1 complex protein DEPDC5
It is part of the GATOR1 complex, which restrains mTORC1 activity when amino acids are limited. Loss-of-function variants cause focal epilepsy with variable penetrance and can contribute to focal cortical dysplasia through somatic second-hit events.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DEPDC5 have source records linked to Autosomal dominant nocturnal frontal lobe epilepsy. Association strength is not clinical gene validity.
GABRG2: Gamma-aminobutyric acid receptor subunit gamma-2
The gene product supplies the gamma-2 subunit of synaptic GABA-A receptors, which are pentameric chloride channels activated by the inhibitory neurotransmitter GABA. The subunit helps receptor assembly and localization at neuronal membranes, and GABRG2 variants are associated with several epilepsy syndromes.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GABRG2 have source records linked to Autosomal dominant nocturnal frontal lobe epilepsy. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant nocturnal frontal lobe epilepsy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CHRNA4 I275F | 275 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| CHRNA4 S280F | 280 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| CHRNA4 S284L | 284 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GABRG2 T317N | 317 | Transmembrane | Pathogenic / likely pathogenic |
| GABRG2 T316N | 316 | Transmembrane | Pathogenic / likely pathogenic |
Same protein, different disease
- Familial febrile seizures also has ClinVar records linked to GABRG2 variants; they fall mostly in different places as the Autosomal dominant nocturnal frontal lobe epilepsy variants (31 pathogenic / likely pathogenic).
- EPILEPSY, CHILDHOOD ABSENCE also has ClinVar records linked to GABRG2 variants; they fall mostly in different places as the Autosomal dominant nocturnal frontal lobe epilepsy variants (28 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to GABRG2 variants; they fall mostly in different places as the Autosomal dominant nocturnal frontal lobe epilepsy variants (8 pathogenic / likely pathogenic).
Diseases related to Autosomal dominant nocturnal frontal lobe epilepsy
- Developmental and epileptic encephalopathy, also linked to DEPDC5, GABRG2 and KCNT1
- Epilepsy, also linked to DEPDC5 and GABRG2
- Generalized epilepsy with febrile seizures plus, also linked to GABRG2
- EPILEPSY, CHILDHOOD ABSENCE, also linked to GABRG2
- Familial febrile seizures, also linked to GABRG2
- Rolandic epilepsy, also linked to GABRG2
- Migraine, also linked to GABRG2
- Genetic developmental and epileptic encephalopathy, also linked to GABRG2
- Malignant migrating partial seizures of infancy, also linked to KCNT1
- Lennox-Gastaut syndrome, also linked to GABRG2
- Epilepsy, familial focal, with variable foci, also linked to DEPDC5
- Familial focal epilepsy with variable foci, also linked to DEPDC5
Frequently asked questions
Which genes have records linked to Autosomal dominant nocturnal frontal lobe epilepsy?
This view contains 4 analyzed proteins: CHRNA4, KCNT1, DEPDC5, GABRG2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 306 variants of uncertain significance and 106 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 556 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center